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Dear Sir,
Vitamin B12 deficiency is responsible for many neuro-
logical disorders and is normally sought in clinical practice
in patients with dementia or ataxia [1, 2]. Parkinsonism
secondary to B12 deficiency is exceedingly rare [2, 3] with
only two previous reports, summarized in Table 1.
A 71-year-old woman with chronic gastritis developed a
rapidly progressive gait disorder with very early falls
within 1 month. She was slightly disoriented and presented
asymmetrical parkinsonism with marked facial hypomimia,
hypophonia, bradykinesia and rigidity (more evident on the
left side and upper limbs), parkinsonian gait with postural
instability (Unified Parkinson Disease Rating Scale part
III—26). Frontal release signs and ideomotor apraxia were
also present. She had no cerebellar nor pyramidal signs, her
proprioception was normal and autonomic dysfunction,
daily fluctuations, visual hallucination or delusions were
not present. No new medication had been started and no
exposure to neuroleptics, carbon-monoxide or toxics was
recorded.
Levodopa was started, 150 mg/day for 2 weeks, then the
dose was increased to 300 mg/day, at which point the pa-
tient became more disoriented, needing help to attain daily
activities and ultimately bedridden, with more marked
motor impairment. It was then suspended. At this time
laboratory studies showed a serious deficit of vitamin
B12 (83 pg/ml, normal [250 pg/ml). Hemoglobin level,
mean corpuscular volume, folate level, thyroid function,
autoimmune and serological screen were normal. She had
no clinical signs or symptoms of myelopathy or neuropa-
thy. Brain MRI revealed mild cortico-subcortical atrophy.
Vitamin B12 replacement was started with injections at a
dose of 1000 mg/day for 7 days, than once a week for
4 weeks and monthly thereafter, with progressive clinical
improvement. Nine months later she was totally indepen-
dent from the functional point of view. She was able to take
care of herself and her house chores including going
shopping on her own. Neurological examination was nor-
mal with no frontal release signs.
The most likely cause of this patient’s parkinsonism and
cognitive deficits was, in our view, the serious B12 deficit
documented, since we have observed full recovery with
replacement therapy and excluded other possible causes.
Pathophysiology of extrapyramidal symptoms in patients
with vitamin B12 deficiency is far from clear. Vitamin B12
has fundamental roles in CNS, especially the methionine-
synthase mediated conversion of homocysteine to me-
thionine [4]. This amino acid is a major source of S-
adenosylmethionine, the most important methyl donor in
the brain and influences serotonin, norepinephrine, and
dopamine synthesis [4]. A deficiency of vitamin B12 may
lead to increased homocysteine levels. And there is evi-
dence that increased homocysteine levels might accelerate
dopaminergic cell death in Parkinson’s disease (PD),
through neurotoxic effects [4]. Other known enzymatic
reaction which is dependent on vitamin B12 is the con-
version of methylmalonic acid to succinyl-CoA, so vitamin
B12 deficiency can lead to increased levels of serum
methylmalonic acid. Also, the methylmalonic acidemia
usually presents with acute extrapyramidal syndrome in
infants and some cases respond to vitamin B12 replacement
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[2]. Brain imaging and autopsy studies of this autosomal
recessive disorder have shown symmetrical involvement of
basal ganglia [2]. Globus pallidus may be especially vul-
nerable because of its high energy requirements [3].
We alert that complicated extrapyramidal and cognitive
manifestations may be, sometimes, due to B12 deficiency
and this recognition is essential since we can easily and
effectively treat these patients.
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